FGF23 and COVID-19: For example, people who had a higher incidence of COVID-19, besides higher levels of plasma FGF23, also were older and had increased rates of diabetes, known risk factors for COVID-19 in the general population and ESRD patients [5,33], which may have influenced the differences in clinical outcomes.